Cereda Lab

Had a blast at the @pezcoller Symposium in Trento! Happy to receive the Travel Grant Award and be awarded by Nobel Laureate William Kaelin🌟 Top-notch speakers, amazing science and connections. Deep thanks to @ceredalab.bsky.social and @IIGMufficiale, and @matteocereda.bsky.social for his mentorship🚀

Amazing days at #EACR2025! Inspiring science, excellent sessions, and such an incredible #cancerResearch community✨ huge thanks to @ceredalab.bsky.social and @matteocereda.bsky.social for the constant support and @IIGM . Also super happy that @AIRC_it stopped by my poster 🌟 @helloeacr.bsky.social

@matteocereda.bsky.social

How soon is now? Very.
Great two-day conference at @fpoirccs @IIGM to embrace the latest advancements in #OvarianCancer research and clinical practice

Had a brilliant morning for a great hands-on session of Lego Serious Play with @ceredalab.bsky.social at #FaciliDay 🌟🌟 exploring how creativity can unlock new spaces of communicating and collaborating

Happy to partecipate in the @embo.org workshop #chromoploidy25 in Stresa! Have been 4 days packed of interesting talks, valuable suggestions and new connections ⭐️ thanks to @matteocereda.bsky.social and the whole @ceredalab.bsky.social

Kudos to @raffaella.ergasti for presenting our ongoing work on #transcriptional #signatures underlying high-grade serous #ovariancancer subtypes in collaboration with Gemelli Hospital at @ESGO_society in Rome 🌟🌟🌟 well done 🙌🙌 #esgo2025

Celebrating Chinese New Year 🧧🐍✨
Excited for the #YearOfTheSnake symbolizing enthusiasm and energy 🔥
Lily and Stephanie’s homemade dumplings were a hit 🥟🌟

RAS-ON inhibition overcomes clinical resistance to KRAS G12C-OFF covalent blockade - Nature Communications KRAS G12C mutant selective inhibitors targeting inactive state have been approved for use in non-small cell lung cancer (NSCLC). Here, using models derived from a patient with NSCLC who progressed on ...

🚨 Thrilled to share also here this exciting and collaborative research on #KRAS G12C adaptive resistance and therapy recently out in @NatureComms

W/ @AmbrogioLab @SantamariaLab @BiagioRicciutiMD

➡️ www.nature.com/articles/s41...

@oncoalert.bsky.social l
@natureportfolio.bsky.social

Sure , added

Sure, added!

Cool, sure! Added

Sure, added!

Added, enjoy!

Sure , added!

Added, thanks!

Added, thanks!

Sure, added!

Added, thanks for your interest!

Added! Thanks for your interest in joining it

would love to be added, thanks!

Poster session is up at #semmretreat24 ⭐️ presenting ongoing PhD project focused on how #RNAprocessing is altered upon genomic instability in #colorectal cancers

Really excited to present it to my PhD peers✨✨

Thanks to @semm_it and @ceredalab.bsky.social

🚀🚀🚀🚀🚀

RAS-ON inhibition overcomes clinical resistance to KRAS G12C-OFF covalent blockade - Nature Communications KRAS G12C mutant selective inhibitors targeting inactive state have been approved for use in non-small cell lung cancer (NSCLC). Here, using models derived from a patient with NSCLC who progressed on ...

🚨 Thrilled to share also here this exciting and collaborative research on #KRAS G12C adaptive resistance and therapy recently out in @NatureComms

W/ @AmbrogioLab @SantamariaLab @BiagioRicciutiMD

➡️ www.nature.com/articles/s41...

@oncoalert.bsky.social l
@natureportfolio.bsky.social

Would love to join this, thanks!

Fellow #RNA lovers, please repost 🙏: 2 ERC-funded Post-doc positions are available in our lab to investigate #RNA structural ensemble and their dynamics in living cells. Application link: t.co/pYJ3H3j705

Here's the #Cancer #Research #2 starter pack 🤩

Researchers, oncologists, patient advocates & more -working across all aspects of cancer research and treatment 🧪🔬⚕️

I also tried to give some exposure to #PhD #students & #postdocs - randomly picked from followers of me or my lab!

go.bsky.app/6EcjWNA

Join! go.bsky.app/51oKcPM

Would love to join the starter pack, thanks!

Would love to be added, thanks!